
Hunting for New Drugs with AI
The pharmaceutical industry is in a drug-discovery slump. How much can AI help?
David H. Freedman is a journalist who has been covering science, business and technology for more than 30 years.

Hunting for New Drugs with AI
The pharmaceutical industry is in a drug-discovery slump. How much can AI help?

Clinical Trials Have the Best Medicine but Do Not Enroll the Patients Who Need It
Most cancer patients never get into lifesaving drug trials because of barriers at community hospitals

Inside NASA's New $18-Billion Deep-Space Rocket
Is NASA's Space Launch System a flying piece of congressional pork or our best shot at getting humans to deep space?

GM Foods on Trial
Proponents of genetically modified crops say the technology is the only way to feed a warming, increasingly populous world. Critics say we tamper with nature at our peril. Who is right?

A Plan to Fix the Obesity Crisis
Science has identified four steps to losing weight that can improve the odds of success

The Truth about Genetically Modified Food
Proponents of genetically modified crops say the technology is the only way to feed a warming, increasingly populous world. Critics say we tamper with nature at our peril. Who is right?

Warped Sense of Time Heightens Temptations
Impulsivity arises from a tendency to want small imminent rewards more than big future benefits. How can we correct our skewed values to care for our future selves?

A Formula for Economic Calamity
Despite the lessons of the 2008 collapse, Wall Street is betting our future on flimsy science

Why Economic Models Are Always Wrong
Financial-risk models got us in trouble before the 2008 crash, and they're almost sure to get us in trouble again

How to Fix the Obesity Crisis
Although science has revealed a lot about metabolic processes that influence our weight, the key to success may lie elsewhere

Jump-Starting the Orbital Economy
Why NASA's plan to get out of the manned spaceflight business may (finally) make space travel routine